The Haryana government announced a policy to boost pharma and medical device manufacturing.

It targets investments worth ₹5,000 crore in the next few years through incentives and support.

Firms can receive up to ₹200 crore in capital expenditure support under the scheme.

Operating expenditure reimbursement up to ₹20 crore is also part of the package.

Startups stand to gain annual reimbursements up to ₹10 lakh for prototype development.

The policy offers R&D incentives, incubation support, and cluster-based manufacturing hubs.

The aim is to cut dependence on imports and make Haryana a manufacturing hub in the sector.

Authorities also want to strengthen export competitiveness with global certifications.

The policy is expected to create jobs and boost regional industrial growth.

It aligns with India’s broader push to build resilient healthcare manufacturing capabilities.